Following on the heels of our partnership announcement with the FDA, we are thrilled to share that we have recently forged an agreement with Ethicon, a Johnson & Johnson company, to support and groom the next generation of medical device innovators. As part of the...
One of my favorite things to do at the Fogarty Institute is visit the Fog Shop, where our medtech startups brainstorm innovative solutions to solve some of the most critical health problems. Not only are these entrepreneurs a great source of inspiration, but they...
Giving birth to a child is perhaps one of the most anticipated, happiest and most celebrated moments of a woman's life. Unfortunately, it is also one of the toughest physical stressors on a woman's body. Surprisingly, it has not received a lot of attention – until...
Last month, Dr. Fogarty, one of the most accomplished medical icons and entrepreneurs, and Tanishq Abraham, one of the brightest young minds in the world, met at the Fogarty Institute for Innovation to share ideas on medical innovation and discuss Tanishq's...
Welcome to the fourth edition of the Fogarty Institute e-newsletter. As always, we have exciting progress being made by our startups, and have enjoyed hosting an increasing pool of visitors who come to the Institute to learn about innovation, what it takes to create a...
We all know that wine and giving are both good for our hearts so we hope you'll join us Friday, September 11, at the 19th Annual "Wine with Heart" event which will raise money for the Fogarty Institute for Innovation. This annual, and much-anticipated event, takes...
One of our recent graduates, InterVene, is making great strides, having recently been approved and funded to do early feasibility clinical trials in New Zealand. The team, led by founder and CEO Fletcher Wilson, left right before Labor Day Weekend. InterVene has...
Igantia Therapeutics, a health and research company, is developing a first-of-its-kind medical device and digital health technology for the treatment and study of an age-related ailment that affects most women – hot flashes. Madorra is developing the first,...
The Fogarty Institute for Innovation is proud to continue to strengthen its presence in women"s healthcare innovation, with the addition of three new startups, which have joined the organization as new companies-in-residence: Igantia Therapeutics, Marz Medical...
Jessie Becker, co-founder and CEO of InPress Technologies, and Surbhi Sarna, founder and CEO of nVision Medical, both made the Forbes "30 Under 30" list. Our companies-in-residence make incredible strides in advancing medical technology on a daily basis and it is...